Table 1.
PPI compared to placebo for EoE | |||||
---|---|---|---|---|---|
Outcomes and follow-up | No. of participants (studies)26–48 | Certainty of the evidence (GRADE) | Relative effect, RR (95% CI) | Anticipated absolute effects | |
Risk with placebo | Risk difference with PPI | ||||
Not achieving histologic remission (<15 eos/hpf); follow-up: mean 8 wk | 1051 (23 observational studies)b | ⊕◯◯◯ VERY LOWc,d | 0.66 (0.61–0.72)e | 867 per 1000 | 295 fewer per 1000 (338 fewer to 243 fewer) |
The risk in the intervention group (and its 95% CI) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
Included 2 RCTs of PPI vs topical steroids.
I2 = 81%; very inconsistent results in absolute terms.
Patients are different than for other interventions where PPI responders were excluded.
Used historical control cohort of placebo arm of topical steroid studies.